Novel cytokines that relate to tumor-associated myeloid cells including osteopontin (OPN) [154], and macrophage inhibitory factor (MIF) [155,156], seem to address the above parameters in that they both regulate myeloid cell trafficking and the immunosuppressive phenotypes in the TME of GBM. The gene discussed is MIF; the disease is neoplasm.